Skip to content

Circular RNAs are a large class of animal RNAs with regulatory potency

Why this mattered

Memczak et al. helped turn circular RNAs from biochemical curiosities into a recognized class of animal regulatory transcripts. The key shift was not merely detecting RNA circles, but showing by transcriptome-wide sequencing and computational analysis that thousands of stable circRNAs are expressed in human, mouse, and C. elegans, often with tissue- or developmental-stage specificity. This challenged the default assumption that most back-spliced products were rare splicing noise or artifacts.

The paper also supplied a compelling functional example: CDR1as, a circular RNA with dozens of conserved miR-7 binding sites, bound miRNA effector complexes and behaved as a miR-7 antagonist in neuronal contexts, with zebrafish experiments linking ectopic CDR1as expression to developmental effects resembling miR-7 loss. That made circRNAs experimentally tractable as regulators of post-transcriptional networks, not just unusual RNA structures.

After this work, circRNA biology became a systematic field: researchers could mine RNA-seq data for back-splice junctions, ask when circularization is regulated, and test whether individual circRNAs act through miRNA binding, protein binding, transcriptional effects, translation, or disease-associated dysregulation. Later studies complicated the early “miRNA sponge” paradigm, showing that CDR1as is unusually site-rich and that many circRNAs likely work by other mechanisms, but that refinement underscores the paper’s importance: it opened the modern question of what covalently closed RNAs do in animals.

Abstract

(no abstract available)

Sources